EUR 48.9
(0.41%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 533.68 Million | 469.33 Million | 682 Million | 715.21 Million | 477.99 Million | 262.65 Million |
Net Income | 404.59 Million | 446.71 Million | 358.05 Million | 197.1 Million | -125.52 Million | 230.69 Million |
Depreciation & Amortization | 141.85 Million | 193.06 Million | 189.56 Million | 257.15 Million | 483.45 Million | 171.41 Million |
Deferred income taxes | -20.86 Million | -33.25 Million | -39.94 Million | 16.8 Million | -21.3 Million | - |
Stock-based compensation | 2.26 Million | 3.29 Million | 7.79 Million | 2.86 Million | 4.03 Million | -484 Thousand |
Change in working capital | -4.35 Million | -49.35 Million | 210.33 Million | 304.28 Million | 192.43 Million | -74.36 Million |
Other non-cash items | 307.48 Million | -121.08 Million | -75.95 Million | -43.32 Million | -72.37 Million | -65.09 Million |
Investing Cash Flow | -213.72 Million | -175.78 Million | -112.47 Million | -91.2 Million | -147.6 Million | -146.88 Million |
Investments in PPE | -228.36 Million | -203.8 Million | -129.85 Million | -97.58 Million | -136.96 Million | -132.06 Million |
Acquisitions | 31.27 Million | 22.26 Million | 2.55 Million | -1.87 Million | -12.63 Million | -32.56 Million |
Investment purchases | -10.09 Million | -12.43 Million | -4.85 Million | -37 Thousand | -4.47 Million | -271 Thousand |
Sales/Maturities of investments | - | - | 6.28 Million | 97.58 Million | 136.96 Million | 132.06 Million |
Other Investing Activities | -6.54 Million | 18.19 Million | 13.41 Million | -89.28 Million | -130.5 Million | -114.05 Million |
Financing Cash Flow | -384.83 Million | -497.55 Million | -479.52 Million | -138.63 Million | -226.1 Million | -112.99 Million |
Debt repayment | -104.34 Million | -55.39 Million | -219.61 Million | -50 Million | -253.1 Million | -492.01 Million |
Dividends payments | -163.71 Million | -159.59 Million | -153.41 Million | -153.41 Million | -153.41 Million | -153.41 Million |
Common Stock Repurchased | -52.74 Million | -205.57 Million | -93.79 Million | - | - | -24.02 Million |
Common Stock Issuance | - | - | - | - | - | 556.57 Million |
Other Financing Activities | -64.03 Million | -76.98 Million | -12.7 Million | 64.77 Million | 180.41 Million | -109 Thousand |
Accounts receivables | -70.85 Million | -47.97 Million | 40.03 Million | 106.08 Million | 19.53 Million | -9.14 Million |
Accounts payables | 33.5 Million | 64.53 Million | 63.33 Million | -41.57 Million | 8.73 Million | 65 Thousand |
Inventory | 26.03 Million | -96.61 Million | 3.33 Million | 177.05 Million | 30.78 Million | -79.46 Million |
Other working capital | 6.96 Million | 30.69 Million | 103.63 Million | 62.72 Million | 133.38 Million | 5.1 Million |
Cash at beginning of period | 718.72 Million | 928.29 Million | 821.84 Million | 354.17 Million | 247.47 Million | 249.49 Million |
Cash at end of period | 623.88 Million | 718.72 Million | 928.29 Million | 821.85 Million | 354.55 Million | 247.9 Million |
Capital Expenditure | -228.36 Million | -203.8 Million | -129.85 Million | -97.58 Million | -136.96 Million | -132.06 Million |
Effect of forex changes on cash | -29.96 Million | -5.57 Million | 16.33 Million | -17.71 Million | 2.41 Million | -4.79 Million |
Net cash flow / Change in cash | -94.84 Million | -209.56 Million | 106.45 Million | 467.67 Million | 107.08 Million | -1.59 Million |
Free Cash Flow | 305.32 Million | 265.53 Million | 552.14 Million | 617.63 Million | 341.03 Million | 130.58 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 97.4 Million | 117.96 Million | 104.94 Million | 404.59 Million | 153.01 Million | 128.03 Million |
Depreciation & Amortization | 49.44 Million | 50.8 Million | 60.57 Million | 141.85 Million | 44.98 Million | 44.06 Million |
Deferred income taxes | - | - | -20.86 Million | -20.86 Million | - | - |
Stock-based compensation | - | - | 2.26 Million | 2.26 Million | - | - |
Change in working capital | -50.79 Million | -175.64 Million | 183.15 Million | -4.35 Million | 69.67 Million | -108.3 Million |
Other non-cash items | 149.67 Million | 4.42 Million | -4.59 Million | 307.48 Million | -32.66 Million | -33.76 Million |
Investing Cash Flow | -38.87 Million | -15.3 Million | -90.43 Million | -213.72 Million | -48.78 Million | -63.76 Million |
Investments in PPE | -41.33 Million | -27.13 Million | -88.66 Million | -228.36 Million | -48.45 Million | -56.04 Million |
Acquisitions | 3.34 Million | -5.97 Million | 4.67 Million | 31.27 Million | -3.35 Million | -1.6 Million |
Investment purchases | -855 Thousand | - | 101 Thousand | -10.09 Million | -119 Thousand | -10.07 Million |
Sales/Maturities of investments | - | - | - | - | 1.82 Million | 2.54 Million |
Other Investing Activities | -32 Thousand | 14.19 Million | -6.54 Million | -6.54 Million | 1.33 Million | 1.41 Million |
Financing Cash Flow | -246.56 Million | -83.02 Million | -71.85 Million | -384.83 Million | -14.34 Million | -182.67 Million |
Debt repayment | -869 Thousand | -524 Thousand | -4.4 Million | -104.34 Million | -4.06 Million | -406 Thousand |
Dividends payments | -168.56 Million | - | - | -163.71 Million | - | -163.71 Million |
Common Stock Repurchased | -60.55 Million | -61.58 Million | -51.42 Million | -52.74 Million | -1000.00 | 1000.00 |
Common Stock Issuance | - | - | - | - | - | -1000.00 |
Other Financing Activities | -2.49 Million | -3.44 Million | -16.02 Million | -64.03 Million | -10.27 Million | -18.55 Million |
Accounts receivables | 11.5 Million | 11.74 Million | -58.5 Million | -70.85 Million | 19.59 Million | -39.5 Million |
Accounts payables | 12.8 Million | -90.28 Million | 67.32 Million | 33.5 Million | -43.42 Million | 23.92 Million |
Inventory | -52.03 Million | -36.83 Million | 109.28 Million | 26.03 Million | 33.45 Million | -67.02 Million |
Other working capital | -23.06 Million | 18.37 Million | 65.05 Million | 6.96 Million | 60.05 Million | -25.7 Million |
Cash at beginning of period | 482.04 Million | 623.88 Million | 483.04 Million | 718.72 Million | 313.77 Million | 535.22 Million |
Cash at end of period | 313.11 Million | 482.04 Million | 623.88 Million | 623.88 Million | 483.04 Million | 313.77 Million |
Capital Expenditure | -41.33 Million | -27.13 Million | -88.66 Million | -228.36 Million | -48.45 Million | -56.04 Million |
Effect of forex changes on cash | -2.6 Million | -601 Thousand | -17.02 Million | -29.96 Million | -2.61 Million | -5.03 Million |
Net cash flow / Change in cash | -168.93 Million | -141.83 Million | 140.84 Million | -94.84 Million | 169.26 Million | -221.45 Million |
Free Cash Flow | 77.78 Million | -70.04 Million | 231.49 Million | 305.32 Million | 186.55 Million | -26.01 Million |
JROOF
600251
3629
AKZOY
PUR
JAGSNPHARM